The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis - Université de Lille Accéder directement au contenu
Article Dans Une Revue ALIMENTARY PHARMACOLOGY & THERAPEUTICS Année : 2019

The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis

Résumé

Further study is needed on the prognostic impact of cirrhosis on haemodialysis patients. To evaluate cirrhosis' impact according to severity on survival and to provide therapeutic guidelines for haemodialysis cirrhotic patients. Patients with end-stage renal failure treated with haemodialysis were included retrospectively from 01/01/2000 to 31/12/2004 and prospectively from 01/01/2005 to 31/12/2014 in our French Region. Clinical data, presence of cirrhosis and its severity were recorded at the beginning of haemodialysis. The primary endpoint was 2-year survival. Seven thousand three hundred and fifty-four patients (96%) without cirrhosis and 304 patients (4%) with cirrhosis were included. Two-year survival in noncirrhotic patients was higher than in cirrhotic patients (71.7% vs 54.4%, P < 0.0001). Patients with decompensated cirrhosis had a worse 2-year outcome (44.1%) as compared to compensated cirrhotic (62.8%, P = 0.002) and noncirrhotic patients (71.7%, P < 0.0001). Compensated and decompensated cirrhosis were independent predictive factors of 2-year mortality. In sensitivity analysis restricted to cirrhotic patients, 2-year survival of Child-Pugh A patients was higher than in Child-Pugh B and C patients (65.5% vs 27.7% vs 0%, P < 0.0001). Development of predictive models based either on severity scores (MELD and Child-Pugh) and extrahepatic comorbidities allowed correct classification of around 70% of patients in terms of mortality and may help to better stratify mortality risk in this population. Cirrhosis is independently associated with mortality in haemodialysis patients. Patients with severe cirrhosis have a poor 2-year outcome. Severity of cirrhosis and presence of extrahepatic comorbidities should be considered when deciding to initiate renal replacement therapy.
Fichier non déposé

Dates et versions

hal-04322577 , version 1 (05-12-2023)

Identifiants

Citer

Florent Artru, Alexandre Louvet, Francois Glowacki, Sara Bellati, Marie Frimat, et al.. The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 50 (1), pp.75-83. ⟨10.1111/apt.15279⟩. ⟨hal-04322577⟩

Collections

RIIP UNIV-LILLE
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More